Literature DB >> 7827204

Secondary acute myeloid leukemia with translocation (4;11) and MLL/AF4 rearrangement in a 15-year-old boy treated for common acute lymphoblastic leukemia 11 years earlier.

R Blütters-Sawatzki1, A Borkhardt, J Grathwohl, R Repp, I Rheinisch-Becker, R M Bohle, F Lampert.   

Abstract

Secondary acute myeloid leukemia occurring in a 15-year-old boy 11 years after initial treatment of a common lymphoblastic leukemia (c-ALL) is described. Initial complete remission was terminated after 4 years by an isolated testicular relapse, followed by first bone marrow relapse within 18 months. After he achieved remission again, an allogeneic bone marrow transplantation from his HLA-identical brother was performed. Five years and 9 months later, the patient developed thrombocytopenia, leukopenia, and anemia, but bone marrow biopsies at this time demonstrated only myelofibrosis, with no blast cell population present. A polymerase chain reaction assay of a peripheral blood sample recognized the mRNA fusion region for the MLL/AF4 rearrangement, i.e., the molecular equivalent of the translocation (4;11)(q21,q23). Four weeks later, a blast cell population with AML-M1 morphology according to the FAB classification appeared in the bone marrow, and translocation (4;11) was detected by cytogenetics. Thus, secondary leukemias with chromosomal 11q23 rearrangement can develop after a long latency period and can be diagnosed earlier with the PCR technique.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7827204     DOI: 10.1007/bf01715379

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  27 in total

1.  Balanced translocations involving chromosome bands 11q23 and 21q22 in therapy-related leukemia.

Authors:  R A Larson; M M Le Beau; M J Ratain; J D Rowley
Journal:  Blood       Date:  1992-04-01       Impact factor: 22.113

2.  Identification of a gene, MLL, that spans the breakpoint in 11q23 translocations associated with human leukemias.

Authors:  S Ziemin-van der Poel; N R McCabe; H J Gill; R Espinosa; Y Patel; A Harden; P Rubinelli; S D Smith; M M LeBeau; J D Rowley
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-01       Impact factor: 11.205

3.  Balanced translocations involving chromosome bands 11q23 and 21q22 are highly characteristic of myelodysplasia and leukemia following therapy with cytostatic agents targeting at DNA-topoisomerase II.

Authors:  J Pedersen-Bjergaard; P Philip
Journal:  Blood       Date:  1991-08-15       Impact factor: 22.113

4.  BFM group treatment results in relapsed childhood acute lymphoblastic leukemia.

Authors:  G Henze; R Fengler; R Hartmann; D Niethammer; G Schellong; H Riehm
Journal:  Haematol Blood Transfus       Date:  1990

5.  The role of DNA topoisomerases in recombination and genome stability: a double-edged sword?

Authors:  J C Wang; P R Caron; R A Kim
Journal:  Cell       Date:  1990-08-10       Impact factor: 41.582

6.  Cytogenetic analyses in 89 patients with secondary hematologic disorders--results of a cooperative study.

Authors:  A Zaccaria; G Alimena; M Baccarani; R Billström; F Carbonell; G L Castoldi; K Fuscaldo; F Hecht; D K Hossfeld; F Mitelman
Journal:  Cancer Genet Cytogenet       Date:  1987-05

7.  Molecular analysis of MLL-1/AF4 recombination in infant acute lymphoblastic leukemia.

Authors:  A Borkhardt; R Repp; E Haupt; S Brettreich; U Buchen; R Gossen; F Lampert
Journal:  Leukemia       Date:  1994-04       Impact factor: 11.528

8.  Acute leukemia with chromosome translocation (4;11): 7 new patients and analysis of 71 cases.

Authors:  F Lampert; J Harbott; W D Ludwig; C R Bartram; J Ritter; V Gerein; M Neidhardt; R Mertens; N Graf; H Riehm
Journal:  Blut       Date:  1987-06

9.  Acute leukemias of different lineages have similar MLL gene fusions encoding related chimeric proteins resulting from chromosomal translocation.

Authors:  J Corral; A Forster; S Thompson; F Lampert; Y Kaneko; R Slater; W G Kroes; C E van der Schoot; W D Ludwig; A Karpas
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-15       Impact factor: 11.205

10.  11q23 abnormalities in children with acute nonlymphocytic leukemia (M4-M5). Association with previous chemotherapy.

Authors:  F Prieto; F Palau; L Badia; M Beneyto; M L Perez-Sirvent; A Orts; V Castel
Journal:  Cancer Genet Cytogenet       Date:  1990-03
View more
  1 in total

Review 1.  MLL-Rearranged Acute Leukemia with t(4;11)(q21;q23)-Current Treatment Options. Is There a Role for CAR-T Cell Therapy?

Authors:  Oliver Britten; Denise Ragusa; Sabrina Tosi; Yasser Mostafa Kamel
Journal:  Cells       Date:  2019-10-29       Impact factor: 6.600

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.